1Institute of Health and Biomedical Innovation at the Queensland Centre for Children's Health Research, School of Exercise and Nutrition Sciences, Queensland University of Technology, Brisbane, QLD, AUSTRALIA; 2Research Center, Franciscan Hospital for Children, Brighton, MA; 3Gait Analysis Laboratory, AI duPont Hospital for Children, Wilmington, DE; 4Department of Physical Therapy and Rehabilitation Sciences, Drexel University, Philadelphia, PA.
Join us on March 2nd for an ActiGraph webinar:
Wearable Data Gone Awry: Cautionary Tales from the Clinical Research Trenches.Register Now
Decision Trees for Detection of Activity Intensity in Youth with Cerebral Palsy
- Published on May 2016
Purpose: To develop and test decision tree (DT) models to classify physical activity (PA) intensity from accelerometer output and Gross Motor Function Classification System (GMFCS) classification level in ambulatory youth with cerebral palsy (CP) and compare the classification accuracy of the new DT models to that achieved by previously published cut points for youth with CP.
Methods Youth with CP (GMFCS levels I-III) (N = 51) completed seven activity trials with increasing PA intensity while wearing a portable metabolic system and ActiGraph GT3X accelerometers. DT models were used to identify vertical axis (VA) and vector magnitude (VM) count thresholds corresponding to sedentary (SED) (<1.5 METs), light-intensity PA (LPA) (≥1.5 and <3 METs) and moderate-to-vigorous PA (MVPA) (≥3 METs). Models were trained and cross-validated using the “rpart” and “caret” packages within R.
Results For the VA (VA_DT) and VM DT (VM_DT), a single threshold differentiated LPA from SED, whereas the threshold for differentiating MVPA from LPA decreased as the level of impairment increased. The average cross-validation accuracies for the VC_DT were 81.1%, 76.7%, and 82.9% for GMFCS levels I, II, and III. The corresponding cross-validation accuracies for the VM_DT were 80.5%, 75.6%, and 84.2%. Within each GMFCS level, the DT models achieved better PA intensity recognition than previously published cut points. The accuracy differential was greatest among GMFCS level III participants, in whom the previously published cut points misclassified 40% of the MVPA activity trials.
Conclusions The GMFCS-specific cut points provide more accurate assessments of MVPA levels in youth with CP across the full spectrum of ambulatory ability.